Casanova et al.
JOCArticle
1H, H-10), 6.85 (m, 1 H, p-CH-OBn), 6.96 (m, 2H, m-CH-OBn),
7.02 (m, 2H, o-CH-OBn), 7.39-7.46 (m, 5H, NBn), 8.31 (s, 1H,
H-2), 10.31 (s, 1H, H-8); 13C NMR (125 MHz, CDCl3) δ 25.2
(CH3), 26.9 (CH3), 36.8 (CH3-N7), 50.3 (CH2N-1), 70.5 (C-50),
72.4 (CH2O), 82.7 (C-30), 86.1 (C-20), 88.7 (C-40), 96.4 (C-10),
113.9 (C(CH3)2), 115.2 (C-5), 126.9, 127.6, 128.0, 137.5 (OBn),
128.9, 129.3, 129.3, 133.8 (NBn), 139.3 (C-8), 144.1 (C-4), 150.5
(C-2), 151.8 (C-6); MS (ES, positive mode) m/z 503 [M]þ. Anal.
Calcd for C28H31IN4O5: C, 53.34; H, 4.96; N, 8.89. Found: C,
53.18; H, 5.02; N, 8.87.
dry DMF (1.0 mL) was added methyl iodide (25 μL, 0.40 mmol).
The reaction was stirred at 60 °C overnight. Volatiles were
removed, and the residue was purified by CCTLC in the
Chromatotron (CH2Cl2:MeOH, 10:1) to yield 7 (50 mg, 49%)
1
as a yellow solid. Mp (CH2Cl2:MeOH) 99-101 °C; H NMR
(500 MHz, CDCl3) δ 1.43, 1.58 (s, 6H, C(CH3)2), 2.20 (s, 3H,
CH3-Ph), 3.70 (dd, J = 10.9, 2.0 Hz, 1H, H-50), 4.06 (s, 3H, CH3-
N7), 4.48 (d, J = 11.0 Hz, 1H, CH2O), 4.61 (dd, J = 10.9, 2.2
Hz, 1H, H-500), 4.69 (d, J = 11.1 Hz, 1H, CH2O), 4.81 (m, 1H,
H-40), 4.99 (d, J = 5.9 Hz, 1H, H-30), 5.13 (d, J = 14.5 Hz, 1H,
CH2N-1), 5.29 (d, J = 14.5 Hz, 1H, CH2N-1), 5.45 (dd, J = 1.4,
5.8 Hz, 1H, H-20), 6.13 (d, J = 1.0 Hz, 1H, H-10), 6.90 (m, 2H,
m-CH-OBn), 6.96 (m, 2H, o-CH-OBn), 7.33-7.45 (m, 5H,
NBn), 8.29 (s, 1H, H-2), 10.31 (s, 1H, H-8); 13C NMR (125
MHz, CDCl3) δ 21.0 (CH3-Ph), 25.2 (CH3), 26.8 (CH3), 36.7
(CH3-N7), 50.0 (CH2N-1), 70.4 (C-50), 72.4 (CH2O), 82.6 (C-30),
86.1 (C-20), 88.7 (C-40), 96.1 (C-10), 113.8 (C(CH3)2), 115.1 (C-5),
127.0, 128.7, 134.7, 137.9 (OBn), 128.5, 129.1, 129.3, 134.2
(NBn), 139.3 (C-8), 144.21 (C-4), 150.7 (C-2), 151.8 (C-6); MS
(ES, positive mode) m/z 517 [M]þ. Anal. Calcd for C29H33-
1-Benzyl-20,30-O-isopropylideneinosine (5).39,40. To a solution
of 20,30-O-isopropylideninosine (3, 500 mg, 1.62 mmol) in
CH3CN (10 mL) were added benzyl bromide (0.17 mL, 1.41
mmol) and DBU (208 μL, 2.14 mmol). The reaction was stirred
at room temperature for 30 min. Volatiles were removed, and
the residue was purified by flash column chromatography
(AcOEt:MeOH, 10:1) to yield 5 (585 mg, 91%) as an amorphous
solid. 1H NMR (300 MHz, CDCl3) δ 1.36, 1.64 (s, 6H, C(CH3)2),
3.78 (m, 1H, H-50), 3.93 (m, 1H, H-500), 4.49 (m, 1H, H-40),
5.03-5.13 (m, 3H, H-30, H-20, OH), 5.16 (m, 2H, CH2N), 5.84
(d, J = 4.2 Hz, 1H, H-10), 7.35 (m, 5H, Ph), 7.87 (s, 1H, H-8),
8.04 (s, 1H, H-2); MS (ES, positive mode) m/z 399 [M þ 1]þ.
1-Benzyl-50-O-(4-methylbenzyl)-20,30-O-isopropylideneinosine
(6). To a solution of 5 (150 mg, 0.38 mmol) in dry DMF (2.5 mL)
were added NaH (60% in mineral oil, 50 mg, 1.24 mmol) and
4-methybenzyl bromide (63 mg, 0.34 mmol). The reaction was
stirred at -20 °C for 30 min, and then it was neutralized by the
addition of AcOH. Volatiles were removed, and the residue was
purified by CCTLC in the Chromatotron (CH2Cl2:MeOH,
20:1) to yield 6 (120 mg, 63%) as an amorphous solid. 1H
NMR (300 MHz, CDCl3) δ 1.35, 1.59 (s, 6H, C(CH3)2), 2.32
(s, 3H, CH3-Ph), 3.57 (dd, J = 10.5, 3.8 Hz, 1H, H-50), 3.64 (dd,
J = 10.5, 3.1 Hz, 1H, H-500), 4.42 (d, J = 11.7 Hz, 1H, CH2O),
4.46 (d, J = 11.7 Hz, 1H, CH2O), 4.52 (m, 1H, H-40), 4.89 (dd,
J = 6.1, 2.2 Hz, 1H, H-30), 5.12 (dd, J = 6.1, 2.7 Hz, 1H, H-20),
5.22 (d, J = 14.7, 1H, CH2N-1), 5.27 (d, J = 14.7, 1H, CH2N-1),
6.10 (d, J = 2.7 Hz, 1H, H-10), 7.10-7.13 (m, 4H, OBn),
7.29-7.35 (m, 5H, NBn), 7.98 (s, 1H, H-8), 8.02 (s, 1H, H-2);
13C NMR (125 MHz, CDCl3) δ 21.1 (CH3-Ph), 25.3 (CH3), 27.2
(CH3), 49.1 (CH2N-1), 69.9 (C-50), 73.5 (CH2O), 81.8 (C-30),
85.3 (C-20), 85.8 (C-40), 91.5 (C-10), 114.1 (C(CH3)2), 124.8 (C-5),
128.0, 129.1, 134.0, 137.7 (OBn), 128.2, 128.3, 129.0, 135.9
(NBn), 138.5 (C-8), 146.9 (C-4), 147.1 (C-2), 156.4 (C-6); MS
(ES, positive mode) m/z 503 [M þ 1] þ. Anal. Calcd for
C28H30N4O5: C, 66.92; H, 6.02; N, 11.15. Found: C, 66.80; H,
6.14; N, 11.09.
IN4O5 H2O: C, 52.57; H, 5.32; N, 8.46. Found: C, 52.36; H,
3
5.10; N, 8.65.
Treatment of 1 with TFA. 1-Benzyl-50-O-benzyl-20,30-O-iso-
propylideneinosine (1, 7.0 mg, 0.014 mmol) was dissolved in
CDCl3 (0.55 mL) and introduced in a NMR tube. A H 1D
1
NMR spectrum was recorded at 298 K. Then, TFA (10.6 μL,
0.143 mmol) was added and a new 1H-1D NMR spectrum was
recorded that corresponds to compound 8. 1H NMR (500 MHz,
CDCl3) δ 1.46, 1.64 (s, 6H, C(CH3)2), 3.69 (dd, J = 10.9, 1.5 Hz,
1H, H-50), 3.91 (dd, J = 10.9, 1.7 Hz, 1H, H-500), 4.24 (d, J =
10.8 Hz, 1H, CH2O), 4.38 (d, J = 10.8 Hz, 1H, CH2O), 4.86 (m,
1H, H-40), 4.94 (d, J = 5.7 Hz, 1H, H-30), 5.17 (d, J = 14.4 Hz,
1H, CH2N-1), 5,28 (d, J = 14.4 Hz, 1H, CH2N-1), 5.29 (d, J =
1.4 Hz, 1H, H-20), 6.16 (d, J = 1.4 Hz, 1H, H-10), 6.89-7.04
(m, 5, OBn), 7.36-7.46 (m, 5H, NBn), 8.26 (s, 1H, H-2), 9.03 (s,
1H, H-8).
Acknowledgment. This research was supported by grants
from the Spanish CICYT [SAF2006-12713-C02] and the
Comunidad de Madrid [BIPEDD-CM, S-BIO/0214/2006].
E.C. thanks the Comunidad de Madrid and the Fondo Social
Europeo (FSE) for a predoctoral fellowship. E-M.P. has a
CSIC contract from the I3P programme financed by the
ꢀ
FSE. L.A. thanks the Spanish Ministerio de Educacion y
Ciencia for a FPU predoctoral fellowship.
1-Benzyl-7-methyl-50-O-(4-methylbenzyl)-20,30-O-isopropyli-
deneinosine Iodide (7). To a solution of 6 (100 mg, 0.20 mmol) in
Supporting Information Available: General chemical pro-
cedures and conditions for NMR studies and molecular dyna-
mics simulations are provided, Figures S1-S7 and Table S1,
and spectra of compounds 2 and 4-8. This material is available
(39) Lichtenthaler, F. W.; Kitahara, K.; Riess, W. Nucleic Acids Res.,
Spec. Publ. 1978, 4, s115-s118.
(40) Montgomery, J. A.; Hewson, K.; Clayton, S. J.; Thomas, H. J.
J. Org. Chem. 1966, 31, 2202–2210.
J. Org. Chem. Vol. 75, No. 6, 2010 1981